Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Inozyme Pharma, Inc. Financials Banner

Inozyme Pharma, Inc. Financials

INZY Stock Analysis

Page title

Section title

INZY Income Statement Key Metrics

  • Revenue(TTM)1.98 M
  • Gross Profit(TTM)967,000
  • EBITDA(TTM)-92.40 M
  • Net Income(TTM)-88.56 M
  • EPS Diluted(TTM)-1.46

Decode INZY's Latest Earnings Call with Ease

Tap 'Generate' for a crystal-clear,
AI-crafted summary and stay ahead in the investment game!

INZY earnings and revenue history

INZY Return on Equity

See how efficiently INZY generates profit for it's shareholders.

-50.66%

10
0
100
  1. Poor

  2. Average

  3. Strong

Return on Equity vs Peers

Return on Equity ratio of INZY (-0.507) is higher than the average of its peers (-0.731).

Return on Equity Growth

INZY's Return on Equity has shown poor growth over the past 10 years, increasing by only -0.16%.

INZY Revenue Growth

See how INZY has grown it's revenue over the past 10 years.


Revenue Growth

INZY's revenue has shown poor growth over the past 10 years, increasing by only 0%.

INZY FY, 2023 Revenue Breakdown

See how INZY converts it's revenue into profit.

INZY Balance Sheet Health

INZY Balance Sheet Breakdown 2023

Assets

  1. Long Term Assets

  2. Cash & Equivalents

  3. Inventory

  4. Receivables

  5. Property Plant Equipments

  6. Others

Liabilities

  1. Short Term Debt

  2. Long Term Debt

  3. Account Payables

  4. Others

INZY financial position analysis

Short Term Liabilities

INZY's short term assets($196M) can safely cover it's short term liabilities($15M).

Long Term Liabilities

INZY's short term assets($196M) can safely cover it's long term liabilities($46M).

INZY Debt to Equity